Theratechnologies Inc T.TH

Tesamorelin phase 4 trial!

[scarlet1967]

 

I didn't know there was an ongoing trial by Columbia University studying Tesamorelin's effect on liver fat, VAT, inflammatory gens etc. among PLWH. 

Only 24 participants, open label, phase4!!

Body Composition and Adipose Tissue in HIV - Full Text View - ClinicalTrials.gov

"In this study, the investigators will examine the effect of therapy with the Growth Hormone Releasing Hormone (GHRH) analog tesamorelin on body composition in patients with HIV lipodystrophy and central adiposity. This study is a single arm prospective study of tesamorelin therapy of patients with HIV lipodystrophy. Subjects will do body composition testing, adipose tissue biopsy, metabolic rate measurements and insulin sensitivity assessment before, 6 and 12 months after daily injections of tesamorelin 2 mg by subcutaneous injection."

[Trogarzon]

More science and paper that will lead to nothing for shareholders.  Greenspoon and the NIH got us a P3 Nash program with their truckload of studies and what now... there is no patent life left in this thing anyway.  Maybe they decide to celebrate this at Thera... maybe it’s a ways to push for a label extension in the lipo indication to cover lipo Nash population... I see the angle

[Marcel49]

Who initiate this study and who pay for it?

[scarlet1967]

Sponsors and Collaborators Columbia University National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)